SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,885.00    75.00 (1.10%)
Bid:
6,875.00
Ask:
6,885.00
Spread: 10.00 (0.145%)
Market Cap: £5.08b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Acquisition

25 Nov 2015 09:00

RNS Number : 8432G
Spirax-Sarco Engineering PLC
25 November 2015
 
25th November 2015Spirax Sarco acquires the business of Flow Smart Inc 

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam, and in peristaltic pumping and associated fluid path technologies, announces that it has acquired the business and assets of Flow Smart Inc., (Flow Smart) for £5.7 million from the founding shareholder and partners. 

Flow Smart, based in Seaford, Delaware USA, specialises in the design and manufacture of high purity sanitary gaskets, silicone transfer tubing and reinforced silicone hoses for the bioprocessing and pharmaceutical industries. The business will be integrated into the Watson-Marlow Fluid Technology Group (WMFTG) and we are pleased that Lou Bongiorno, founder and President of Flow Smart, will transfer along with existing staff to our new company, Watson-Marlow Flow Smart, Inc., and continue in his role as President.

Flow Smart is a natural extension and supplement to the WMFTG fluid path product portfolio and further strengthens WMFTG's extensive global presence in the biotechnology and pharmaceutical industries, which includes Watson-Marlow Pumps, Watson-Marlow Tubing, Flexicon Filling Systems, BioPure single-use tubing connector systems, Aspeco aseptic valves and Alitea OEM Pumps. Flow Smart's product range utilises market-leading technology to improve sterility within the biotechnology production process, thereby reducing validation risk in demanding contamination-free applications and enhancing customer confidence.

The purchase consideration will be paid in cash at completion from the Group's existing resources. The acquisition is expected to generate an immediate small benefit to Group earnings per share.

 

Enquiries:

Nick Anderson, Chief Executive

David Meredith, Director Finance

Tel: 01242 535234

 

About Spirax Sarco

Spirax-Sarco Engineering plc is the world leader in each of its two businesses, Spirax Sarco for steam specialties and Watson-Marlow Fluid Technology Group for niche peristaltic pumps and associated fluid path technologies. The steam specialties business provides a broad range of fluid control products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. The company helps its customers to improve production efficiency, reduce energy costs, water usage and emissions, improve product quality and enhance the safety of their operations. Watson-Marlow Fluid Technology Group offers the ideal solution for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance free pumps and associated technologies. The Group is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 4,800 people, of whom around 1,300 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX).

Further information can be found at www.spiraxsarcoengineering.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAXFLAALSFFF
Date   Source Headline
20th Nov 20085:11 pmRNSTransaction in Own Shares
19th Nov 20085:28 pmRNSTransaction in Own Shares
18th Nov 20085:27 pmRNSTransaction in Own Shares
17th Nov 20085:16 pmRNSTransaction in Own Shares
14th Nov 20085:07 pmRNSTransaction in Own Shares
13th Nov 20085:26 pmRNSTransaction in Own Shares
12th Nov 20085:10 pmRNSTransaction in Own Shares
11th Nov 20085:19 pmRNSTransaction in Own Shares
10th Nov 20085:17 pmRNSTransaction in Own Shares
10th Nov 20082:12 pmRNSDirector/PDMR Shareholding
7th Nov 20087:00 amRNSInterim Management Statement
5th Nov 20085:22 pmRNSHolding(s) in Company
4th Nov 20089:56 amRNSAcquisition
3rd Nov 20082:54 pmRNSTotal Voting Rights
7th Oct 20089:24 amRNSDirector/PDMR Shareholding
1st Oct 20089:38 amRNSTotal Voting Rights
30th Sep 200810:52 amRNSDirector/PDMR Shareholding
1st Sep 20082:36 pmRNSTotal Voting Rights
27th Aug 20087:00 amRNS2008 Half Year Results
11th Aug 200812:36 pmRNSNotice of Results
8th Aug 20083:15 pmRNSHolding(s) in Company
1st Aug 20083:55 pmRNSTotal Voting Rights
2nd Jul 20082:10 pmRNSTotal Voting Rights
18th Jun 200811:55 amRNSHolding(s) in Company
16th Jun 200812:21 pmRNSHolding(s) in Company
9th Jun 20084:45 pmRNSHolding(s) in Company
4th Jun 20082:33 pmRNSNotification of Major Interes
2nd Jun 20089:00 amRNSTotal Voting Rights
21st May 20084:12 pmRNSDirector/PDMR Shareholding
15th May 20083:54 pmRNSHolding(s) in Company
15th May 20083:37 pmRNSHolding(s) in Company
13th May 200812:00 pmRNSInterim Management Statement
13th May 200812:00 pmRNSInterim Management Statement
1st May 200810:03 amRNSTotal Voting Rights
1st Apr 200810:32 amRNSTotal Voting Rights
12th Mar 20084:55 pmRNSDirector/PDMR Shareholding
11th Mar 200812:11 pmRNSDirector/PDMR Shareholding
10th Mar 20087:01 amRNSFinal Results
3rd Mar 20089:09 amRNSTotal Voting Rights
3rd Mar 20088:54 amRNSAcquisition
27th Feb 20083:49 pmRNSNotice of Results
1st Feb 20081:41 pmRNSTotal Voting Rights
1st Feb 20081:39 pmRNSAcquisition
4th Jan 20089:57 amRNSTotal Voting Rights
20th Dec 20075:02 pmRNSDirector/PDMR Shareholding
20th Dec 20074:58 pmRNSDirector/PDMR Shareholding
13th Dec 200710:23 amRNSBoard Changes
3rd Dec 200711:39 amRNSTotal Voting Rights
16th Nov 20075:41 pmRNSHolding(s) in Company
12th Nov 20073:22 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.